Geeves M A
Department of Biochemistry, School of Medical Sciences, University of Bristol, U.K.
Biochemistry. 1989 Jul 11;28(14):5864-71. doi: 10.1021/bi00440a024.
The equilibrium and dynamics of the interaction between actin, myosin subfragment 1 (S1), and ADP have been investigated by using actin which has been covalently labeled at Cys-374 with a pyrene group. The results are consistent with actin binding to S1.ADP (M.D) in a two-step reaction, A + M.D K1 equilibrium A-M.D K2 equilibrium A.M.D, in which the pyrene fluorescence only monitors the second step. In this model, K1 = 2.3 X 10(4) M-1 (k+1 = 4.6 X 10(4) M-1 s-1) and K2 = 10 (k+2 less than or equal to 4 s-1); i.e., both steps are relatively slow compared to the maximum turnover of the ATPase reaction. ADP dissociates from both M.D and A-M.D at 2 s-1 and from A.M.D at greater than or equal to 500 s-1; therefore, actin only accelerates the release of product from the A.M.D state. This model is consistent with the actomyosin ATPase model proposed by Geeves et al. [(1984) J. Muscle Res. Cell Motil. 5, 351]. The results suggest that A-M.D cannot break down at a rate greater than 4 s-1 by dissociation of ADP, by dissociation of actin, or by isomerizing to A.M.D. It is therefore unlikely to be significantly occupied in a rapidly contracting muscle, but it may have a role in a muscle contracting against a load where the ATPase rate is markedly inhibited. Under these conditions, this complex may have a role in maintaining tension with a low ATP turnover rate.
通过使用在半胱氨酸-374处用芘基团共价标记的肌动蛋白,研究了肌动蛋白、肌球蛋白亚片段1(S1)和ADP之间相互作用的平衡及动力学。结果与肌动蛋白以两步反应结合S1.ADP(M.D)一致,即A + M.D⇌K1平衡A-M.D⇌K2平衡A.M.D,其中芘荧光仅监测第二步。在该模型中,K1 = 2.3×10⁴ M⁻¹(k⁺1 = 4.6×10⁴ M⁻¹ s⁻¹)且K2 = 10(k⁺2≤4 s⁻¹);也就是说,与ATP酶反应的最大周转率相比,两步反应都相对较慢。ADP以2 s⁻¹的速率从M.D和A-M.D解离,从A.M.D解离的速率≥500 s⁻¹;因此,肌动蛋白仅加速A.M.D状态下产物的释放。该模型与Geeves等人提出的肌动球蛋白ATP酶模型一致[(1984年)《肌肉研究与细胞运动杂志》5,351]。结果表明,A-M.D不能通过ADP解离、肌动蛋白解离或异构化为A.M.D以大于4 s⁻¹的速率分解。因此,它不太可能在快速收缩的肌肉中大量存在,但可能在对抗负荷收缩的肌肉中起作用,在这种情况下ATP酶速率受到明显抑制。在这些条件下,这种复合物可能在以低ATP周转率维持张力方面起作用。